Trials / NCT02465749
Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Status unknown Early Phase 1 Supplement / diet, Drug / neuroprotection
- Sponsor
- Sun Yat-sen University
- Treatment
- Continuous oxygen; blue light-absorbing sunglasses; Compound thrombosis capsule sig: 1.5g/tid; Ginkgo biloba pills sig: 300mg/tid;; Vitamin B sig: 10mg/tid; Vitamin AD sig: 1 tablet/tid
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 60 Years
- Enrollment
- 404 participants
- Started
- 2015-05
- Main results expected
- 2025-06
- Results posted
- Not yet
- Record last updated
- 2015-06-08
What the study is testing
The purpose of this study is to investigate the role of continuous oxygen therapy combined with blue light deprivation in prevention and control of retinitis pigmentosa, in order to find a new strategy of treatment for retinitis pigmentosa.
Where it runs
China (1)
- State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong